April Vogelsang, RN, MS, currently serves as the System Senior Vice President & Chief Clinical Integration Officer at Health Alliance Medical Plans & Carle Health, having worked in the Carle system since 2006. She has provided progressive healthcare and health services leadership experience since 1996, with expertise in government business, matrix management, interdisciplinary project management, and aligning operational tactics with strategic initiatives. She provides strategic and operational oversight for integrated enterprise strategy for Population Health and Health Alliance Clinical Operations (Case Management, Population Health, Health Coaching and Prevention/Wellness, Utilization Management, Quality Services, Pharmacy, and Risk Adjustment Solutions), including the Stratum Med Accountable Care Organization (ACO).
She holds a Master of Science in Health Services Administration, and is a member of the American College of Healthcare Executives (ACHE), America’s Health Insurance Plans (AHIP), the Alliance of Community Health Plans (ACHP) and Illinois Organization of Nurse Leaders. Additionally she serves on the Board of Directors for CIMRO and Great Plains Quality Innovation Network. She has contributed to local and national publications (Journal of Managed Care Nursing) and presented at numerous national conferences.
26. How to Succeed in Population Health Across Risk-Bearing Entities and Value-Based Payment Arrangements
Hidden opportunities can be found among health systems and other risk-bearing entities to improve the quality and decrease the costs of providing healthcare to at-risk patient populations. Discover how Health Alliance, a vertically integrated health system with a health plan and population health organization, found and maximized these opportunities by breaking down the barriers between entities to accomplish two fundamental goals:
- Implement a system-wide structure to manage sustainable population health efforts.
- Develop and implement a population health care model that improves the quality and reduces costs associated with a fully at-risk (capitated) population.
Early reviews of the population data, even accounting for the impact of COVID-19, show a 30 to 40% reduction in ED utilization and 27% decrease in readmissions. Data supports a 2.8:1 return on investment.
Participants will learn:
- Where population health staff must be embedded to make the biggest difference.
- What goals matter most when creating scalable population health programs.
- How program value can be proven even during utilization changes (such as those caused by COVID).